Increased Lipid Oxidation Heralds Diabetes Onset in DR.lyp/lyp Rats

Abstract

Aim: The BB rat model of type 1 diabetes exhibits altered body weight gain and body temperature regulation prior to hyperglycemia onset, implying the existence of as yet unidentified biomarkers of autoimmune processes that destroy pancreatic beta cells. To investigate this hypothesis, we compared the metabolic profile of diabetes-resistant DR.lyp/+ rats and their diabetes-prone, congenic DR.lyp/lyp littermates in the days leading up to diabetes onset.

Methods: Except for the Gimap5 mutation on chromosome 4, congenic DR.lyp/lyp rats are genetically identical to DR.lyp/+ littermates. They invariably develop hyperglycemia at 46–81 days of age, whereas DR.lyp/+ rats do not develop diabetes. In addition to daily food intake and body weight, indirect calorimetry was performed continuously on male DR.lyp/lyp and DR.lyp/+ rats (n=6/group) for 6–18 days to measure locomotor activity, VO₂, VCO₂ and RQ.

Results: DR.lyp/lyp rats exhibited a progressive decrease of RQ compared to DR.lyp/+ rats 0.005±0.001 units/day (p<0.005). Limiting the analysis to the six days prior to diabetes onset revealed a larger decrease of 0.007±0.002 units/day (p<0.001) in DR.lyp/lyp animals, whereas RQ of the DR.lyp/+ rats remained unchanged. This metabolic change occurred prior to hyperglycemia onset and was not associated with changes of any other parameter.

Conclusions: Diabetes onset in DR.lyp/lyp rats is heralded by a progressive shift towards lipid oxidation relative to carbohydrate metabolism.

pre-diabetes - metabolism - biomarker - prediction of type 1 diabetes

References

• 1 Akesson L, Hawkins T, Jensen R, Fuller JM, Breslow NE, Lernmark A. Decreased core temperature and increased beta(3)-adrenergic sensitivity in diabetes-prone bb rats.  Diabetes technology & therapeutics. 2007;  9 354-362
• 2 Bieg S, Koike G, Jiang J, Klaff L, Pettersson A, MacMurray AJ, Jacob HJ, Lander ES, Lernmark A. Genetic isolation of iddm 1 on chromosome 4 in the biobreeding (bb) rat.  Mamm Genome. 1998;  9 324-326
• 3 Bieg S, Simonson W, Ellefsen K, Lernmark A. Rel b is an early marker of autoimmune islet inflammation in the biobreeding (bb) rat.  Pancreas. 2000;  20 47-54
• 4 Bingley PJ, Gale EA. Progression to type 1 diabetes in islet cell antibody-positive relatives in the european nicotinamide diabetes intervention trial: The role of additional immune, genetic and metabolic markers of risk.  Diabetologia. 2006;  49 881-890
• 5 Fuller JM, Kwitek AE, Hawkins TJ, Moralejo DH, Lu W, Tupling TD, Macmurray AJ, Borchardt G, Hasinoff M, Lernmark A. Introgression of f344 rat genomic DNA on bb rat chromosome 4 generates diabetes-resistant lymphopenic bb rats.  Diabetes. 2006;  55 3351-3357
• 6 Kukreja A, Maclaren NK. Autoimmunity and diabetes.  The Journal of clinical endocrinology and metabolism. 1999;  84 4371-4378
• 7 MacMurray AJ, Moralejo DH, Kwitek AE, Rutledge EA, Yserloo B Van, Gohlke P, Speros SJ, Snyder B, Schaefer J, Bieg S, Jiang J, Ettinger RA, Fuller J, Daniels TL, Pettersson A, Orlebeke K, Birren B, Jacob HJ, Lander ES, Lernmark A. Lymphopenia in the bb rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (ian)-related gene.  Genome research. 2002;  12 1029-1039
• 8 Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH. Affinity-purified human interleukin i is cytotoxic to isolated islets of langerhans.  Diabetologia. 1986;  29 63-67
• 9 Markholst H, Eastman S, Wilson D, Fisher L, Lernmark A. Decreased weight gain in bb rats before the clinical onset of insulin-dependent diabetes.  Diabetes research and clinical practice. 1993;  21 31-38
• 10 Michalkiewicz M, Michalkiewicz T, Ettinger RA, Rutledge EA, Fuller JM, Moralejo DH, Yserloo B Van, MacMurray AJ, Kwitek AE, Jacob HJ, Lander ES, Lernmark A. Transgenic rescue demonstrates involve-ment of the ian5 gene in t cell development in the rat.  Physiological genomics. 2004;  19 228-232
• 11 Moralejo DH, Park HA, Speros SJ, MacMurray AJ, Kwitek AE, Jacob HJ, Lander ES, Lernmark A. Genetic dissection of lymphopenia from autoimmunity by introgression of mutated ian5 gene onto the f344 rat.  Journal of autoimmunity. 2003;  21 315-324
• 12 Mordes JP, Bortell R, Blankenhorn EP, Rossini AA, Greiner DL. Rat models of type 1 diabetes: Genetics, environment, and autoimmunity.  ILAR journal/National Research Council, Institute of Laboratory Animal Resources. 2004;  45 278-291
• 13 Newsholme P, Keane D, Welters HJ, Morgan NG. Life and death decisions of the pancreatic beta-cell: The role of fatty acids.  Clin Sci (Lond). 2007;  112 27-42
• 14 Pearl-Yafe M, Kaminitz A, Yolcu ES, Yaniv I, Stein J, Askenasy N. Pancreatic islets under attack: Cellular and molecular effectors.  Current pharmaceutical design. 2007;  13 749-760
• 15 Pighin D, Karabatas L, Pastorale C, Dascal E, Carbone C, Chicco A, Lombardo YB, Basabe JC. Role of lipids in the early developmental stages of experimental immune diabetes induced by multiple low-dose streptozotocin.  J Appl Physiol. 2005;  98 1064-1069
• 16 Pihoker C, Gilliam LK, Hampe CS, Lernmark A. Autoantibodies in diabetes.  Diabetes. 2005;  54 ((Suppl 2)) 52-61
• 17 Pinhero JC BD. Mixed-effects models in s and s-plus. New York: Springer-Verlag 2000
• 18 Ramanathan S, Poussier P. Bb rat lyp mutation and type 1 diabetes.  Immunological reviews. 2001;  184 161-171
• 19 Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS. Patterns of metabolic progression to type 1 diabetes in the diabetes prevention trial-type 1.  Diabetes care. 2006;  29 643-649
• 20 Vertrees S, Wilson CA, Ubungen R, Wilson D, Baskin DG, Toivola B, Jacobs C, Boiani N, Baker P, Lernmark A. Interleukin-1 beta regulation of islet and thyroid autoimmunity in the bb rat.  Journal of autoimmunity. 1991;  4 717-732
• 21 Wilson CA, Jacobs C, Baker P, Baskin DG, Dower S, Lernmark A, Toivola B, Vertrees S, Wilson D. Il-1 beta modulation of spontaneous autoimmune diabetes and thyroiditis in the bb rat.  J Immunol. 1990;  144 3784-3788
• 22 Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP. The role of insulin resistance in predicting the progression to type 1 diabetes.  Diabetes care. 2007;  30 2314-2320
• 23 Yale JF, Grose M, Marliss EB. Time course of the lymphopenia in bb rats. Relation to the onset of diabetes.  Diabetes. 1985;  34 955-959

1 These authors contributed equally to this article.

Correspondence